Treatment of Cholangiocarcinoma
Copyright © Targeted News Service 2024
2024-11-05
ALEXANDRIA, Virginia, Nov. 5 -- JANSSEN PHARMACEUTICA NV, Beerse, Belgium has been assigned a patent (No. US 12133851 B2, initially filed Sept. 19, 2019) developed by Jacqueline Cirillo Bussolari, Raritan, New Jersey, for "Treatment of cholangiocarcinoma." . . .